SCHEMBL12856719

SCHEMBL12856719

Cc1cc2c(O)c(c1)Cc1cccc(c1O)Cc1cc(C)cc(c1O)Cc1cccc(c1O)C2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 2/20 0.39
▸ PTPN2 P17706 5/20 0.39
▸ PTPN1 P18031 5/20 0.39
▸ PTPN11 Q06124 5/20 0.39
▸ PTPRB P23467 5/20 0.39
▸ PTPRC P08575 4/20 0.39
▸ GSTA1 P08263 4/20 0.39
▸ GSTP1 P09211 4/20 0.39
▸ ING2 Q9H160 1/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ SELL P14151 1/20 0.39
▸ SELP P16109 1/20 0.39
▸ SELE P16581 1/20 0.39
▸ MAPT P10636 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ USP2 O75604 1/20 0.38
▸ HPN P05981 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ ALOX5 P09917 1/20 0.38
▸ THRB P10828 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18538300 1.00 ACHE (0.39) ACHEPTPN2PTPN1PTPN11PTPRB
SCHEMBL13287042 0.88 SELL (0.48) ACHEPTPN2PTPN1PTPN11PTPRB
SCHEMBL12856781 0.85 GSTA1 (0.41) ACHEPTPN2PTPN1PTPN11PTPRB
SCHEMBL19762894 0.84 ING2 (0.68) PTPN2PTPN1PTPN11PTPRBPTPRC
SCHEMBL18538310 0.83 PTPN1 (0.43) PTPN2PTPN1PTPN11PTPRBALDH1A1
SCHEMBL29644944 0.83 ALDH1A1 (0.48) PTPN2PTPN1PTPN11PTPRBPTPRC
SCHEMBL29366399 0.83 ALDH1A1 (0.48) PTPN2PTPN1PTPN11PTPRBPTPRC
SCHEMBL29383145 0.83 ALDH1A1 (0.48) PTPN2PTPN1PTPN11PTPRBPTPRC
SCHEMBL2471777 0.83 ALDH1A1 (0.48) PTPN2PTPN1PTPN11PTPRBPTPRC
SCHEMBL29469562 0.83 ALDH1A1 (0.48) PTPN2PTPN1PTPN11PTPRBPTPRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110028676-A1 Molecular Actuators, and Methods of Use Thereof MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2011-02-03 — — US disclosed
US-7658868-B2 Class of molecular actuators where bulk actuation mechanisms such as ion intercalation are enhanced by controllable single molecule conformational rearrangements offers promise in exhibiting large active strains at moderate stresses MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2010-02-09 — — US disclosed
US-20070215839-A1 Molecular actuators, and methods of use thereof MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2007-09-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070215839-A1 Molecular actuators, and methods of use thereof NOD2, PIEZO1, TPR ACHE 3471/4885PTPN2 3195/4885PTPN1 3727/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback